Search results
May 16, 2024 · Welcome to Parkinson's Resource Organization, created more than thirty years ago to maximize quality of life for people with Parkinson’s and their families/caregivers through education, resources, and person-to-person support. Browse our support group offerings and our digital resource directory, The Wellness Village Resource Directory -- the ...
Apr 30, 2024 · Parkinson's is a progressive neurodegenerative disease that worsens over time and is incurable. Patients lose dopamine-producing brain cells important for normal movement. Symptoms include ...
May 5, 2024 · Després de pocs dies de jubilar-se i amb 50 anys de trajectòria, el periodista esportiu de TV3, Lluís Canut, ha anunciat en una entrevista amb Albert Om al diari Ara que pateix de Parkinson . Assegura que ja feia sis o set anys que li havien diagnosticat aquesta malaltia i que «cap al final de l’ Efectivament, m’afectava a la mobilitat ...
5 days ago · Parkinson's disease is a degenerative disorder of the nervous system, which most scientists agree originates in the brain. We know that Parkinson's disease causes damage to the nerves in the brain, which in turn reduces dopamine cells, but did you also know that this leads to an accumulation of alpha-synuclein, known more commonly as Lewy ...
5 days ago · The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million with PD in the United States live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested ...
6 days ago · The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson’s disease (PD) and works tirelessly to help the approximately one million with PD in the United States live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested ...
May 10, 2024 · Prexton Therapeutics. Country: Switzerland | Funding: $41.1M. Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson's disease.
